Cross-resistance between rifampicin and KRM-1648 is associated with specific rpoB alleles in Mycobacterium tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 6, Issue 2, 2002, Pages 166-170

  Park, Y K ^a   Kim, B J ^a   Ryu, S ^a   Kook, Y H ^a   Choe, Y K ^a   Bai, G H ^a   Kim, S J ^a  

^a Korean Institute of Tuberculosis   (South Korea)

Author keywords

Cross resistance; KRM 1648; M. tuberculosis; Rifampicin; RpoB gene

Indexed keywords

RIFALAZIL; RIFAMPICIN;

ALLELE; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; CODON; CROSS RESISTANCE; DIAGNOSTIC VALUE; GENE ISOLATION; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RPOB GENE; STRAIN IDENTIFICATION;

ALLELES; BASE SEQUENCE; DNA, BACTERIAL; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, MULTIPLE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; RIFAMPIN; RIFAMYCINS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

EID: 0036210173     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis
2. Detection of rifampicin-resistant mutations in Mycobacterium tuberculosis
3. Synthesis and biological activity of 3′-hydroxy-5′ aminobenzoxazinorifamycin derivatives
4. In vitro and in vivo activities of the benzoxazinorifamycin KRM-1648 against Mycobacterium tuberculosis
5. Drug resistance of Mycobacterium tuberculosis in Korea
6. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City
7. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB)
8. Restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolated from countries in the Western Pacific region
9. Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations
10. Contribution of rpoB mutations to development of rifamycin cross-resistance in Mycobacterium tuberculosis
11. Relationship between anti-mycobacterial activities of rifampicin, rifabutin and KRM-1648 and rpoB mutations of Mycobacterium tuberculosis
12. Mycobacterium tuberculosis rpoB gene DNA sequencing: Implications for detection of rifamycin resistance
13. Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureus
14. Detection of rifampin resistance in Mycobacterium tuberculosis by double gradient-denaturing gradient gel electrophoresis
15. Comparative bioequivalence study of rifampicin and isoniazid combinations in healthy volunteers